Association between sarcopenia and a prognosis in patients undergoing percutaneous endoscopic gastrostomy
Not Applicable
- Conditions
- Patients undergoing percutaneous endoscopic gastrostomy
- Registration Number
- JPRN-UMIN000047005
- Lead Sponsor
- The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 127
Inclusion Criteria
Not provided
Exclusion Criteria
Those who meet at least one of the following inclusion criteria 1. Patients with advanced cancer 2. Patients who underwent PEG for the purpose of decompression of the gastrointestinal tract 3. Patients in which the cross-sectional CT images at the third lumber vertebra level were not available 4. Patients with missing body height data 5. Patients who refused to participate by opting out
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Overall survival between low and high groups of skeletal muscle mass index at the level of the third lumbar vertebra (L3-SMI)
- Secondary Outcome Measures
Name Time Method 1) Overall survival between low and high groups of psoas muscle mass index at the level of the third lumbar vertebra (L3-PMI) 2) Overall survival between low and high groups of skeletal muscle radiation attenuation at the level of the third lumbar vertebra (L3-MRA) 3) Overall survival between low and high group of L3-SMI in the covariate-balancing propensity score-matched subgroup [Cut-off values] L3-SMI: female, 29.6 cm2/m; male, 36.2 cm2/ m2 L3-PMI: female, 3.92 cm2/m2; male, 6.36 cm2/ m2 L3-MRA: female, 39.3 cm2/m2; male, 44.4 cm2/m2